| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MET proto-oncogene, receptor tyrosine kinase | 0.380 | 0.846 | 0.97 |
|
phenotype | 0.400 | None | 0.972 | 3 | 0 | 1995 | 2020 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.100 | None | 0.983 | 2 | 0 | 1995 | 2020 | ||||||||
|
bone morphogenetic protein 6 | 0.531 | 0.808 | 0.76 |
|
phenotype | 0.100 | None | 0.857 | 2 | 0 | 1995 | 2017 | ||||||||
|
ETS variant transcription factor 4 | 0.545 | 0.500 | 2.9E-08 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 1995 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
phenotype | 0.100 | None | 1.000 | 2 | 0 | 1995 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.100 | None | 0.925 | 2 | 0 | 1995 | 2020 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
phenotype | 0.100 | None | 0.944 | 1 | 0 | 1995 | 2019 | ||||||||
|
cyclin dependent kinase 4 | 0.412 | 0.808 | 6.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 1995 | 2019 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 18 | 0 | 1996 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 6 | 0 | 1996 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.400 | None | 0.989 | 4 | 0 | 1996 | 2020 | ||||||||
|
matrix metallopeptidase 14 | 0.447 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 0.989 | 4 | 0 | 1996 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
phenotype | 0.100 | None | 0.959 | 3 | 0 | 1996 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
phenotype | 0.100 | None | 0.944 | 3 | 0 | 1996 | 2020 | ||||||||
|
integrin subunit alpha 6 | 0.539 | 0.769 | 1.9E-07 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 1996 | 2019 | ||||||||
|
integrin subunit beta 3 | 0.485 | 0.846 | 1.7E-03 |
|
phenotype | 0.100 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
phenotype | 0.400 | None | 0.960 | 2 | 0 | 1996 | 2019 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 0.962 | 2 | 0 | 1996 | 2020 | ||||||||
|
superoxide dismutase 2 | 0.379 | 0.923 | 0.15 |
|
phenotype | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2019 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
glutathione S-transferase mu 1 | 0.380 | 0.923 | 2.1E-03 |
|
phenotype | 0.050 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
somatostatin | 0.399 | 0.885 | 0.34 |
|
phenotype | 0.100 | None | 0.913 | 1 | 0 | 1996 | 2019 | ||||||||
|
versican | 0.497 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 0 | 1996 | 2019 | ||||||||
|
fragile histidine triad diadenosine triphosphatase | 0.444 | 0.846 | 5.7E-03 |
|
phenotype | 0.080 | None | 1.000 | 1 | 0 | 1996 | 2017 |